期刊文献+

5722次肾移植患者他克莫司浓度监测的临床应用分析 被引量:2

下载PDF
导出
摘要 目的:探讨肾移植患者他克莫司(FK-506)治疗窗浓度与毒副作用及排异反应的关系.方法:应用微粒子免疫分析法测263例肾移植患者口服FK-506后12h的血药谷浓度,并对监测结果进行比较分析.结果:5722例次FK-506全血谷浓度中4280例次 在5-15ng/ml的范围内.当他克莫司浓度〉15ng/ml易导致高血糖,〉20ng/ml易导致肾中毒,〈5ng/ml则易产生排斥反应.结论:常规监测他克莫司全血浓度,避免浓度过高或过低,及时调整患者用药情况,实施个体化用药方案,可使患者获得满意的免疫抑制治疗效果.
出处 《医学信息(下旬刊)》 2011年第3期3-4,共2页 Medical information
  • 相关文献

参考文献10

  • 1First MR. Taerolimuus based immunsuppression [J]. J Nephrol, 2004,17(suppl 8) :525--531. 被引量:1
  • 2邱实,刘龙,杨宏伟,郭时英,李昕,范连慧,曹志强,何城,向军.不同群体肾移植患者他克莫司临床应用初步探讨[J].中国药师,2005,8(11):938-940. 被引量:3
  • 3Ventaramanan R, Swaminathan A, Prasad 7, et aL Clinical pharma cokinetics of tacrolirnus [J ]. Clin Pharmacokinet 1995, 29 : 404 --430. 被引量:1
  • 4Usko WJ,Thomson A W, Fung J J, et al. Consensus document: therapeutic monitoring of tacrolimus ( FK -- 506 ) [J ], The drug Monit, 1995,17 : 606-- 614. 被引量:1
  • 5Jindal RM. Posttransplantation diabetes mellitus-- a review[J]. Transplantation, 1994,58(12) : 1289 -- 1298. 被引量:1
  • 6Pirsch JD, Miller J, Deierhoi MH, et al. A comparision of tacroli- mus(FK--506) and cyclosporine for immunosuppression after ca- daveric renal transplantation, 1997,15 (7) : 977-- 83. 被引量:1
  • 7Mayer AD, Dmitrewski J, Squifflet JP, et al . Multicenter random- ized trial comparing tacrolimus(FK-- 506) and cyclosporine in the prevention of renal allograft rejection:a report of the European ta- crolimus multicenter renal study group[J], Transplantation, 1997,15(3):436--43. 被引量:1
  • 8Vincenti F, Laskow DA, Neylan J F, et al. One- year follow- up of an oper-- label trial of FK-- 506 for primary kidney transplanta- tion. A report of the US. Multieenter FK--506 kidney. Transplan- tation Group [J]. Transplantation,1996,15(ll) :1576--81. 被引量:1
  • 9王振,高江平,罗芸,卢锦山,敖建华,肖序仁,洪宝发,石炳毅,薛毅珑.不同浓度他克莫司在体外对胰岛的毒性作用及致糖尿病作用的临床研究[J].中华器官移植杂志,2006,27(11):681-684. 被引量:15
  • 10Drachenberg CB,Klassen D K,Weir MR,et al. Islet cell damage associated with tacrolimus and cyclosporine: Morphological fea- tures in pancreas allograft biopsies and clinical correlation [J]. Transplantation, 1999,68(3) : 396-- 402. 被引量:1

二级参考文献18

  • 1Pirsch JD,Miller J,Deierhoi MH,et al.A comparison of tacrolimus(FK506)and cyclosporine for immunosuppression after cadaveric renal transplantation [J].Transplantation,1997,63:977-983. 被引量:1
  • 2Hutton J.The economics of immunosuppression in renal transplantation:a review of recent literature[J].Transplant Proc,1999,31:1328-1332. 被引量:1
  • 3Schleibner S,Krauss M,Wagner K et al,Fk-506 versus cyclosporin in the prevention of renal allograft rejection.European pilot study:six-week results[J].Transpl Int,1995,8:86-90. 被引量:1
  • 4Kihira K,Kadoyama M,Miyake K,et al.Pharmacokinetic behavior of cyclosporine A in liver dysfunction[J].Hiroshima J Med Sci,1994,43(4):175-178. 被引量:1
  • 5European Tacrolimus Multicentre Renal Study Group.Multicentre randomized trial comparing tacrolimus(FK506) and cyclosporin in the prevention of renal allograft rejection:a report of the European Tacrolimus Multicentre Renal Study Group[J].Transplantation,1997,64:436-443. 被引量:1
  • 6Meredith M, Li G, Metz SA. Inhibition of calcium-induced insulin secretion from intact HIT-T15 or INS-1 beta cells by GTP depletion. Biochem Pharmacol, 1997,53 : 1873-1882. 被引量:1
  • 7Ishizuka J, Gugliuzza KK, Wassmuth Z, et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation, 1993,56 : 1486-1490. 被引量:1
  • 8Gray DW, McShane P, Grant A, et al. A method for isolation of islets of Langerhans from the human pancreas. Diabetes, 1984,33 : 1055-1061. 被引量:1
  • 9Warnock GL, Ellis D, Rajotte RV, et al. Studies of the isolation and viability of human islets of Langerhans. Transplantation,1988,45 : 957-963. 被引量:1
  • 10Latif ZA, Noel J,Alejandro R. et al. A simple method of staining fresh and cultured islets. Transplantation, 1988,45 : 827-830. 被引量:1

共引文献16

同被引文献10

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部